Table of Contents
ISRN Oncology
Volume 2012, Article ID 642141, 8 pages
Review Article

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer

1Molecular and Cell Biology Program, Ohio University, Athens, OH, USA
2Biomedical Engineering Program, Russ College of Engineering and Technology, Ohio University, Athens, OH, USA
3Department of Biomedical Sciences, College of Osteopathic Medicine, Ohio University, Athens, OH, USA

Received 20 October 2011; Accepted 10 November 2011

Academic Editors: D. Mezzanzanica, A. E. Pinto, and M. J. Turk

Copyright © 2012 Maria Muccioli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Yuzheng Huang, Bing Cai, Ming Xu, Zhiqin Qiu, Yonghui Tao, Ying Zhang, Jie Wang, Yongliang Xu, Yonghua Zhou, Jing Yang, Xiaofeng Han, and Qi Gao, “Gene Silencing of Toll-Like Receptor 2 Inhibits Proliferation of Human Liver Cancer Cells and Secretion of Inflammatory Cytokines,” Plos One, vol. 7, no. 7, 2012. View at Publisher · View at Google Scholar
  • Sabina Kaczanowska, Ann Mary Joseph, and Eduardo Davila, “TLR agonists: our best frenemy in cancer immunotherapy,” Journal of Leukocyte Biology, vol. 93, no. 6, pp. 847–863, 2013. View at Publisher · View at Google Scholar
  • Jun Pan, Xiaoyong Zhao, Chunnan Lin, Hongchao Xu, Zhilin Yin, Tianzhu Liu, and Shizhong Zhang, “Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma,” Oncology Reports, vol. 32, no. 5, pp. 1957–1966, 2014. View at Publisher · View at Google Scholar
  • Claudio Lera Orsatti, Eliana Aguiar Petri Nahas, Jorge Nahas-Neto, Fabio Lera Orsatti, Vanessa Innocenti Giorgi, and Steven S. Witkin, “Evaluation of Toll-Like Receptor 2 and 4 RNA Expression and the Cytokine Profile in Postmenopausal Women with Metabolic Syndrome,” Plos One, vol. 9, no. 10, 2014. View at Publisher · View at Google Scholar
  • Wenna Shi, Lihui Su, Qianqian Li, Lidan Sun, Jing Lv, Jun Li, and Baoquan Cheng, “Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma.,” Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 10, pp. 9627–37, 2014. View at Publisher · View at Google Scholar
  • Neha Pandey, and Shashi Pandey-Rai, “Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production,” Protoplasma, 2015. View at Publisher · View at Google Scholar
  • Snehal M. Gaikwad, Bhushan Thakur, Asmita Sakpal, Ram K. Singh, and Pritha Ray, “Differential activation of NF-κB signaling is associated with Platinum and Taxane resistance in MyD88 deficient epithelial ovarian cancer cells,” The International Journal of Biochemistry & Cell Biology, 2015. View at Publisher · View at Google Scholar
  • Luiz Gustavo A Chuffa, Francisco Eduardo Martinez, Beatriz A Fioruci-Fontanelli, Leonardo O Mendes, Fábio R Ferreira Seiva, Marcelo Martinez, Wagner J Fávaro, Raquel F Domeniconi, Patrícia F F Pinheiro, and Lucilene Delazari Dos Santos, “Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.,” BMC cancer, vol. 15, pp. 34, 2015. View at Publisher · View at Google Scholar
  • Hao Wu, Lin Gao, Feng Li, Fei Song, Xiaofei Yang, and Nikola Kasabov, “Identifying overlapping mutated driver pathways by constructing gene networks in cancer.,” BMC bioinformatics, vol. 16Suppl5, 2015. View at Publisher · View at Google Scholar
  • Aysegul Cort, Tomris Ozben, Luciano Saso, Chiara De Luca, and Liudmila Korkina, “Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants,” Oxidative Medicine and Cellular Longevity, vol. 2016, pp. 1–17, 2016. View at Publisher · View at Google Scholar